Skip to content

Drug interactions

Letermovir + Zileuton

Severity: Moderate

Letermovir and Zileuton: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir inhibits CYP3A moderately and may raise concentrations of CYP3A substrates, and zileuton is partly metabolized by CYP3A4. Zileuton exposure could increase, with a greater risk of dose-related adverse effects, especially hepatotoxicity.

What this interaction means in plain words

Letermovir and Zileuton can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Letermovir belongs to Anti Virals; Zileuton belongs to Respiratory.

Evidence level: Low

Why it happens

Letermovir inhibits CYP3A4, reducing the metabolic clearance of zileuton.

What to do

Monitor ALT at baseline and periodically during combined use, and reduce or stop zileuton if liver enzymes rise or symptoms of hepatic injury appear.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Letermovir and Zileuton, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Letermovir with Zileuton?

MediHelp rates the interaction as moderate. Letermovir and Zileuton can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Letermovir inhibits CYP3A moderately and may raise concentrations of CYP3A substrates, and zileuton is partly metabolized by CYP3A4. Zileuton exposure could increase, with a greater risk of dose-related adverse effects, especially hepatotoxicity.

How serious is the interaction between Letermovir and Zileuton?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ALT at baseline and periodically during combined use, and reduce or stop zileuton if liver enzymes rise or symptoms of hepatic injury appear.

What other medicines interact with Zileuton?

MediHelp also lists interactions of Zileuton with, for example, Fezolinetant, Pimozide, Alosetron. The full list is on the Zileuton page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in